Discover 213 paid clinical trials in Knoxville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 213
Active & Responsive
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
for
Emphysema, Pulmonary, Emphysema or COPD
Location: Knoxville TN, Pittsburgh PA, Falls Church VA,
Sponsor: Pulmonx Corporation
Sex: All
Age: 40 - 70+
Code: NCT06035120
Recruiting
Active & ResponsiveNew
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for
Smoking Cessation
Location: Knoxville TN, Stockbridge GA, Evansville IN, Memphis TN,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07766655
Phase3, Recruiting
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Powell TN, Oak Ridge TN, Lexington KY, Tullahoma TN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase3, Recruiting
Active & Responsive
Daily Eating Patterns for Total Health Study
for
Obesity
Location: Knoxville TN
Sponsor: The University of Tennessee, Knoxville
Sex: All
Age: 25 - 60
Code: NCT06455995
Recruiting
Active & Responsive
Early Childhood Dietary Assessment Study
for
Dietary Assessment
Location: Knoxville TN
Sponsor: The University of Tennessee, Knoxville
Sex: All
Age: 2 - 5
Code: NCT07227272
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Knoxville TN, Chattanooga TN, Atlanta GA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase2, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Location: Knoxville TN, Asheville NC, Johnson City TN, Hixson TN,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07496567
Phase2, Phase3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Knoxville TN, Atlanta GA, Nashville TN, Indianapolis IN,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Oak Ridge TN, Chattanooga TN, Cumming GA, Gantt SC,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Corbin KY, Johns Creek GA, Lexington KY, Decatur GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Knoxville TN, Lexington KY, Atlanta GA, Nashville TN,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase2, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Knoxville TN, Atlanta GA, Louisville KY, Chapel Hill NC,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase3, Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Knoxville TN, Chattanooga TN, Atlanta GA, Nashville TN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase2, Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Knoxville TN, Atlanta GA, St Louis MO, Duarte CA
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07544654
Phase3, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)